SPOTLIGHT: FDA expands Humira approval

The FDA has expanded its approval of Abbott Laboratories' Humira for psoriatic arthritis. The drug can be used to inhibit structural damage and improve physical activity in patients. The agency approved Humira for psoriatic arthritis a year ago. Report